3 August 2016
DETAILS
Arkema: quarterly information–
2nd quarter 2016 results
• Strong EBITDA growth up 7% to €341 million
(€320 million in 2Q 2015) driven by
the three divisions and volumes 2.6 % higher
compared to 2Q 2015
• 17.5% EBITDA margin close to historic highs,
supported by very high margins
in High Performance Materials and
Industrial Specialties
• €134 million adjusted net income 9%
up on 2Q 2015 (+28% on first half of the year)
and €1.79 adjusted net income per share
• Solid cash generation with
+€77 million free cash flow 1 and
net debt overall stable at €1,406 million
despite €143 million dividend payment
• 2016 outlook: Arkema now targets
significant EBITDA growth of
some 7% to 9% over the year compared to 2015
Thierry Le Hénaff
Chariman and CEO
“Following a very good start to the year,
the Group confirms in 2 nd quarter
its development momentum
with satisfactory progress in volumes,
a very good financial performance and
a 17.5% EBITDA margin significantly up on last year.
These results reflect in particular
the ongoing rapid ramp-up of Bostik
with a profitability which further improves.
The planned acquisition of Den Braven,
announced in July, will reinforce this activity
in the coming years and contribute
to the strong growth ambition
we have for our adhesives.
The many actions conducted
by our teams have contributed
to the high results achieved in almost all product lines.
We are also proud of the growing successes
of our innovation in new materials
which allow us to support our customers,
in particular in Technical Polymers.
Finally, we confirm the progress made over
the last quarters in cash generation.
For 2016 as a whole, even though
we prefer to remain cautious
about the global economic environment,
the excellent first half of the year
supports our confidence
in our ability to achieve a very good year.”
VIEW ARKEMA'S Q2 2016 FULL PRESENTATION
WWW.CHEMWINFO.COM BY KHUN PHICHAI
